Translational Development Acquisition Corp.

Last updated September 27, 2026

Organization details

Legal name
Translational Development Acquisition Corp.
Ownership
Public
Status
Active
Sector (GICS)
Financials
SIC code
6770 — Blank Checks
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
TDAC
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001926599

Board of directors

Chief executives

Michael B. Hoffman · Chief Executive Officer
Since December 2024

Board connections

1 of this board's directors also sit on 1 other board.

Network of Translational Development Acquisition Corp.'s board connections Annovis Bio Inc. Annovis Bio Inc. Michael B. Hoffman Michael B. Hoffman Translational Development...
Shared director Other board Same sector

Organizations in the same sector, closest in location and size first.

Questions about Translational Development Acquisition Corp.

Who is the CEO of Translational Development Acquisition Corp.?

Michael B. Hoffman has been Translational Development Acquisition Corp.'s Chief Executive Officer since December 2024.

How many directors are on Translational Development Acquisition Corp.'s board?

Translational Development Acquisition Corp.'s board has 5 directors: Christopher Kenneth Jarratt, Curtis T. Keith, E. Premkumar Reddy, Matthew Kestenbaum and Michael B. Hoffman.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="translational-development-acquisition-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.